Gilead Sciences Europe Ltd is a research-based biopharmaceutical company that discovers, develops and commercialises innovative medicines in areas of unmet medical need. We strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead Sciences Europe Ltd's portfolio of products and pipeline of investigational drugs includes treatments for HIV, viral hepatitis, cancer and inflammation, serious respiratory and cardiovascular conditions.
Collaborations with local communities are central to our work. Partnerships enhance our ability to develop innovative medicines and deliver them to people as efficiently as possible.
We are committed to delivering educational and support materials that truly meet patient needs. We work closely with community representatives to develop and deliver resources that are appropriate, culturally sensitive and relevant. In many cases, these are designed to improve dialogue between patients and physicians and to improve awareness about conditions such as HIV.
For medical information questions please contact Gilead Sciences Europe Medical Information on +44 (0)208 587 2394 or by email to email@example.com
If you experience any side effects whilst on your medication, talk to your doctor or pharmacist. Side effects related to Gilead products may be reported directly to Gilead at Safety_FC@gilead.com or you can call the Medical Information team on the above number. You can also report side effects via the national reporting schemes.
Please note that we are unable to provide medical advice on an individual patient’s symptoms. If you are a patient and are concerned about your symptoms, or they worsen, please contact your doctor or healthcare provider immediately.